ONGOING CLINICAL TRIAL: A PROSPECTIVE MULTICENTRE, PHASE 2B RANDOMISED, CONTROLLED DOUBLE-BLIND TRIAL TO DETERMINE THE SAFETY AND EFFICACY OF PERISPINAL ETANERCEPT ON QUALITY OF LIFE

被引：0

作者：

Thijs, V. ^{[1
]}

Bernhardt, J. ^{[1
]}

Cloud, G. ^{[2
]}

Churilov, L. ^{[3
]}

Sprigg, N. ^{[4
]}

Parsons, B. ^{[1
]}

Gilchrist, N. ^{[5
,6
]}

Walker, M. ^{[6
,7
]}

Bath, P. ^{[7
]}

机构：

[1] Florey Inst Neurosci & Mental Hlth, Stroke Theme, Heidelberg, Vic, Australia

[2] Alfred Hlth, Stroke, Melbourne, Vic, Australia

[3] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia

[4] Univ Nottingham, Sch Med, Stroke Trials Unit, Nottingham, England

[5] CGM Res Trust, Cgm, Christchurch, New Zealand

[6] Univ Nottingham UK, Div Rehabil Ageing & Wellbeing, Nottingham, England

[7] Nottingham Univ Hosp NHS Trust, Stroke, Dept Med, Nottingham, England

来源：

INTERNATIONAL JOURNAL OF STROKE | 2021年 / 16卷 / 2_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

WSC21-222

引用

页码：27 / 27

页数：1

共 50 条

[31] Efficacy and safety of emodepside compared with albendazole in adolescents and adults with hookworm infection in Pemba Island, Tanzania: a double-blind, superiority, phase 2b, randomised controlled trial
Taylor, Lyndsay
Ahmada, Ahmada Ali
Ali, Msanif Said
Ali, Said Mohammed
Hattendorf, Jan
Mohammed, Ibrahim Said
Keiser, Jennifer
LANCET, 2024, 404 (10453): : 683 - 691
[32] EFFICACY AND SAFETY OF TELMISARTAN, CLOPIDOGRELIN, AND LEFLUNOMIDE IN PATIENTS WITH IgA NEPHROPATHY - A MULTICENTRE, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND AND -DUMMY CONTROLLED CLINICAL TRIAL
Wu, Jie
Duan, Shuwei
Li, Wenge
Wang, Yaping
Liu, Wenhu
Zhang, Jianrong
Lun, Lide
Li, Xuemei
Zhou, Chunhua
Zheng, Ying
Liu, Shuwen
Xie, Yuansheng
Cai, Guangyan
Chen, Xiangmei
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 175 - 175
[33] Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
Tyring, S
Gottlieb, A
Papp, K
Gordon, K
Leonardi, C
Wang, A
Lalla, D
Woolley, M
Jahreis, A
Zitnik, R
Cella, D
Krishnan, R
LANCET, 2006, 367 (9504): : 29 - 35
[34] Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial
Coarelli, Giulia
Heinzmann, Anna
Ewenczyk, Claire
Fischer, Clara
Chupin, Marie
Monin, Marie-Lorraine
Hurmic, Hortense
Calvas, Fabienne
Calvas, Patrick
Goizet, Cyril
Thobois, Stephane
Anheim, Mathieu
Nguyen, Karine
Devos, David
Verny, Christophe
Ricigliano, Vito A. G.
Mangin, Jean-Francois
Brice, Alexis
du Montcel, Sophie Tezenas
Durr, Alexandra
LANCET NEUROLOGY, 2022, 21 (03): : 225 - 233
[35] Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Henzi, Bettina C.
Schmidt, Simone
Nagy, Sara
Rubino-Nacht, Daniela
Schaedelin, Sabine
Putananickal, Niveditha
Stimpson, Georgia
Consortium, North Star
Amthor, Helge
Childs, Anne-Marie
Deconinck, Nicolas
de Groot, Imelda
Horrocks, Iain
Opstal, Saskia Houwen-van
Laugel, Vincent
Lobato, Mercedes Lopez
Garrido, Marcos Madruga
Osorio, Andres Nascimento
Schara-Schmidt, Ulrike
Spinty, Stefan
von Moers, Arpad
Lawrence, Fiona
Hafner, Patricia
Dorchies, Olivier M.
Fischer, Dirk
LANCET NEUROLOGY, 2023, 22 (10): : 890 - 899
[36] The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial
McMurray, John J. V.
Freeman, Mason W.
Massaro, Joe
Solomon, Scott
Lock, Paul
Riddle, Matthew C.
Halvorsen, Yuan-Di C.
DIABETES, 2020, 69
[37] Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Mercuri, Eugenio
Vilchez, Juan J.
Boespflug-Tanguy, Odile
Zaidman, Craig M.
Mah, Jean K.
Goemans, Nathalie
Mueller-Felber, Wolfgang
Niks, Erik H.
Schara-Schmidt, Ulrike
Bertini, Enrico
Comi, Giacomo P.
Mathews, Katherine
Servais, Laurent
Vandenborne, Krista
Johannsen, Jessika
Messina, Sonia
Spinty, Stefan
Mcadam, Laura
Selby, Kathryn
Byrne, Barry
Laverty, Chamindra G.
Carroll, Kevin
Zardi, Giulia
Cazzaniga, Sara
Coceani, Nicoletta
Bettica, Paolo
Mcdonald, Craig M.
LANCET NEUROLOGY, 2024, 23 (04): : 393 - 403
[38] Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Traboulsee, Anthony
Greenberg, Benjamin M.
Bennett, Jeffrey L.
Szczechowski, Lech
Fox, Edward
Shkrobot, Svitlana
Yamamura, Takashi
Terada, Yusuke
Kawata, Yuichi
Wright, Padraig
Gianella-Borradori, Athos
Garren, Hideki
Weinshenker, Brian G.
LANCET NEUROLOGY, 2020, 19 (05): : 402 - 412
[39] Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Di Lorenzo, Carlo
Khlevner, Julie
Rodriguez-Araujo, Gerardo
Xie, Wangang
Huh, Susanna Y.
Ando, Masakazu
Hyams, Jeffrey S.
Nurko, Samuel
Benninga, Marc A.
Simon, Michael
Hewson, Marcella E.
Saps, Miguel
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (03): : 238 - 250
[40] Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety
Keshvari, Amir
Mollamohammadi, Leila
Keramati, Mohammad Reza
Behboudi, Behnam
Fazeli, Mohammad Sadegh
Kazemeini, Alireza
Naseri, Amirhossein
Shahmohammadi, Elnaz
Foroutani, Laleh
Ayati, Aryan
Tayebi, Amirhossein
Sajjadian, Zahra
Hadizadeh, Alireza
Ahmadi-Tafti, Seyed-Mohsen
UPDATES IN SURGERY, 2023, 75 (04) : 847 - 854

← 1 2 3 4 5 →